Share your insights

Help us by sharing what content you've recieved in your exams


Bipolar affective disorder

Background knowledge 🧠

Definition

  • Bipolar affective disorder (BPAD) is a chronic mental health condition characterized by recurrent episodes of mood disturbances that range from mania/hypomania to depression.
  • Formerly known as manic-depressive illness.
  • Affects mood, energy levels, and ability to function.
  • Mood episodes can last weeks to months.

Epidemiology

  • Lifetime prevalence is approximately 1-2% globally.
  • Equal prevalence in males and females.
  • Onset typically occurs between ages 15-30.
  • Higher prevalence in high-income countries.
  • Genetic predisposition is significant.

Aetiology and pathophysiology

  • Multifactorial: genetic, neurobiological, and environmental factors.
  • Imbalance in neurotransmitters (e.g., serotonin, dopamine).
  • Genetic factors: first-degree relatives have a 10-fold increased risk.
  • Stressful life events can trigger episodes.
  • Structural brain abnormalities: e.g., prefrontal cortex, amygdala.

Types

  • Bipolar I: characterized by at least one manic episode, often with major depressive episodes.
  • Bipolar II: characterized by at least one hypomanic episode and one major depressive episode.
  • Cyclothymic disorder: chronic, fluctuating mood disturbance with periods of hypomania and depressive symptoms that do not meet criteria for major depression.
  • Rapid cycling: four or more mood episodes within a year.
  • Mixed features: simultaneous symptoms of mania/hypomania and depression.

Clinical Features 🌑️

Symptoms

  • Manic symptoms: elevated mood, increased energy, reduced need for sleep, grandiosity, racing thoughts, impulsive behavior.
  • Depressive symptoms: low mood, anhedonia, fatigue, feelings of worthlessness, suicidal ideation.
  • Hypomanic symptoms: similar to mania but less severe; no psychosis.
  • Psychotic symptoms: may occur during severe episodes of mania or depression.
  • Cognitive impairment may persist between episodes.

Signs

  • Pressured speech.
  • Increased psychomotor activity.
  • Flight of ideas.
  • Distractibility.
  • Delusions or hallucinations (in severe cases).
  • Poor insight.

Investigations πŸ§ͺ

Tests

  • Clinical diagnosis primarily based on history and mental state examination.
  • Mood questionnaires (e.g., Mood Disorder Questionnaire) may aid diagnosis.
  • Rule out organic causes: thyroid function tests, electrolytes, drug screening.
  • Imaging (e.g., MRI) not routinely indicated unless ruling out structural brain lesions.
  • Baseline investigations before starting medications: FBC, U&Es, LFTs, ECG.

Management πŸ₯Ό

Management

  • Pharmacological: mood stabilizers (e.g., lithium, valproate), antipsychotics (e.g., quetiapine, olanzapine).
  • Antidepressants may be used cautiously with mood stabilizers.
  • Psychotherapy: CBT, psychoeducation, family therapy.
  • Lifestyle modifications: regular sleep, stress management, avoiding alcohol and recreational drugs.
  • Crisis intervention: may require hospitalization for severe episodes.
  • Long-term monitoring and follow-up are essential to manage relapses.

Complications

  • High risk of suicide: up to 20 times higher than the general population.
  • Substance abuse disorders are common.
  • Increased risk of cardiovascular disease.
  • Social and occupational impairment.
  • Adverse effects of long-term medication use (e.g., renal impairment from lithium).

Prognosis

  • Chronic and relapsing course; 60-70% of patients have recurrent episodes.
  • Early treatment and adherence improve outcomes.
  • Poor prognosis associated with mixed features, rapid cycling, and comorbid substance abuse.
  • Lifelong treatment often necessary to prevent relapse.
  • With effective treatment, many patients can achieve good functional recovery.

Key points

  • Early identification and treatment are crucial to improving outcomes.
  • Long-term follow-up with regular monitoring for mood changes and medication side effects.
  • Educating patients and families about the nature of the disorder can improve adherence and outcomes.
  • Interdisciplinary care (including GPs, psychiatrists, and psychologists) is key to successful management.

No comments yet πŸ˜‰

Leave a Reply